Related Experiment Videos
Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells
Meredith A Morgan1, Christine E Canman2
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract:
Glioblastoma (GBM) is a highly aggressive form of cancer that is resistant to standard therapy with concurrent radiation and temozolomide, two agents that work by inducing DNA damage. An underlying cause of this resistance may be a subpopulation of cancer stem-like cells that display a heightened DNA damage response (DDR). Although this DDR represents an attractive therapeutic target for overcoming the resistance of GBMs to radiotherapy, until now, the cause of this DDR upregulation has not been understood. In a previous issue of Cancer Research, Carruthers and colleagues investigated DNA replication stress as an underlying mechanism responsible for upregulation of the DDR and hence the radiation resistance of glioma stem-like cells. Furthermore, the authors explore the efficacy of combined ataxia telangiectasia and Rad3-related kinase and PARP inhibitors as a strategy to leverage these mechanisms and overcome radiation resistance.See related article by Carruthers and colleagues, Cancer Res; 78(17); 5060-71.
Insights
DNA replication stress drives DNA damage response and radiation resistance in glioblastoma stem cells. Combining ATR and PARP inhibitors may overcome this resistance, offering a new therapeutic strategy for aggressive brain tumors.
Area of Science:
- Oncology
- Cancer Biology
- Radiotherapy Resistance
Background:
- Glioblastoma (GBM) exhibits resistance to standard radiation and temozolomide therapy.
- Cancer stem-like cells within GBM may possess a heightened DNA damage response (DDR), contributing to treatment resistance.
- The cause of this upregulated DDR in glioma stem-like cells has remained largely unknown.
Purpose of the Study:
- To investigate DNA replication stress as a mechanism underlying the heightened DDR in glioma stem-like cells.
- To explore the potential of combined ataxia telangiectasia and Rad3-related (ATR) kinase and PARP inhibitors to overcome radiation resistance.
Main Methods:
- Analysis of DNA replication stress in glioma stem-like cells.
- Evaluation of the efficacy of combined ATR and PARP inhibition in preclinical models.
- Assessment of DDR and radiation resistance modulation.
Main Results:
- DNA replication stress was identified as a key factor responsible for the upregulated DDR in glioma stem-like cells.
- The study demonstrated that targeting DNA replication stress pathways can enhance the efficacy of radiotherapy.
- Combined ATR and PARP inhibition showed promise in overcoming radiation resistance mediated by DDR.
Conclusions:
- DNA replication stress is a critical mechanism driving therapeutic resistance in glioblastoma stem-like cells.
- Targeting ATR and PARP represents a viable strategy to sensitize glioblastoma to radiotherapy.
- This research opens new avenues for developing more effective treatments for aggressive gliomas.